The Chronic Disease Treadmill Enslaves Generations

Metabolic chronic conditions are consuming Medicaid funds at an alarming rate, surpassing even the defense budget, reflecting a systemic issue in healthcare spending. Pharmaceutical companies are exploiting this by promoting lifelong treatments for preventable conditions, framing them as genetic and inevitable. This narrative, supported by institutions like Harvard and the NIH, labels obesity and related health issues as brain diseases rather than results of lifestyle choices. Such a shift in perspective not only undermines personal agency but also risks bankrupting the country by inflating healthcare costs. With Medicaid poised to cover exorbitant prices, lower-income populations become targets for ongoing medication dependency, perpetuating a cycle of chronic disease management rather than fostering genuine health improvements.